Circulating endothelial cells: new biomarker of the endothelial dysfunction in hematological malignancies

Nicolas Gendron; Nicolas Gendron; David M. Smadja; David M. Smadja

doi:10.1684/abc.2015.1080

Related publications

Article2016

Circulating endothelial cells: a new biomarker of endothelial dysfunction in hematological diseases

Nicolas Gendron, Nicolas Gendron, David M. Smadja, David M. Smadja

Article2009

Circulating Endothelial Cells

David M. Smadja, David M. Smadja, Pascale Gaussem, Pascale Gaussem, Laëtitia Mauge, Laëtitia Mauge, Dominique Israël‐Biet, Dominique Israël‐Biet, Françoise Dignat‐George, Françoise Dignat‐George, Séverine Peyrard, Séverine Peyrard, Gabriella Agnoletti, Gabriella Agnoletti, Pascal Vouhé, Pascal Vouhé, Damien Bonnet, Damien Bonnet, Marilyne Lévy, Marilyne Lévy

Letter2024

Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19

David M. Smadja, David M. Smadja, Sven Günther, Sven Günther, Pauline Cavagna, Pauline Cavagna, Bertrand Renaud, Bertrand Renaud, Dominique Salmon, Dominique Salmon, Bertrand Hermann, Bertrand Hermann, Brigitte Ranque, Brigitte Ranque, Cédric Lemogne, Cédric Lemogne, Jean-Luc Diehl, Jean-Luc Diehl, Aurélien Philippe, Aurélien Philippe

Article2020

The DNA methylation landscape of hematological malignancies: an update

Pedro Blecua, Laura Martinez‐Verbo, Manel Esteller

Article2015

The real face of endothelial progenitor cells – Circulating angiogenic cells as endothelial prognostic marker?

Neli Kachamakova‐Trojanowska, Karolina Bukowska-Straková, Monika Żukowska, Jozef Dulak, Alicja Józkowicz